Amman Bradford K. 4
4 · Vivos Therapeutics, Inc. · Filed Dec 28, 2022
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-23$0.48/sh+200,000$96,000→ 500,001 totalExercise: $0.48Exp: 2027-12-23→ Common Stock (500,001 underlying)
Footnotes (1)
- [F1]200,000 stock options granted on December 23, 2022. One-fifth vests annually on each anniversary date through December 23, 2026.